Changes

Iodinated contrast in pregnancy, when orally administered, is harmless.<ref name=acog>{{cite web|url=https://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Guidelines-for-Diagnostic-Imaging-During-Pregnancy-and-Lactation|title=Guidelines for Diagnostic Imaging During Pregnancy and Lactation|website=[[American Congress of Obstetricians and Gynecologists]]}} February 2016</ref> Intravenous administration of iodinated radiocontrast agents can cross the placenta and enter the fetal circulation, but animal studies have reported no teratogenic or mutagenic effects from its use. There have been theoretical concerns about potential harm of free iodide on the fetal [[thyroid gland]],<ref name=acog/> but multiple studies have shown that a single dose of intravenously administered iodinated contrast medium to a pregnant mother has no effect on neonatal thyroid function.<ref>{{cite web|url=https://www.acr.org/~/media/37D84428BF1D4E1B9A3A2918DA9E27A3.pdf|title=ACR Manual on Contrast Media. Version 10.3|year=2017|website=American College of Radiology|publisher=American College of Radiology Committee on Drugs and Contrast Media|accessdate=2017-07-30}}</ref> Nevertheless, it generally is recommended that radiocontrast only be used if absolutely required to obtain additional diagnostic information that will improve the care of the fetus or mother.<ref name=acog/>